Tinnitus

Variant: 1 Pulsatile tinnitus, unilateral or bilateral; No retrotympanic lesion on otoscopy. Initial imaging.

Procedure	Appropriateness Category	Relative Radiation Level
MRA head with IV contrast	Usually Appropriate	O
MRI head and internal auditory canal without and with IV contrast	Usually Appropriate	O
CTA head and neck with IV contrast	Usually Appropriate	☢☢☢
CTA head with IV contrast	Usually Appropriate	☢☢☢
MRA head without and with IV contrast	May Be Appropriate (Disagreement)	O
MRA head without IV contrast	May Be Appropriate	O
MRI head and internal auditory canal without IV contrast	May Be Appropriate	O
MRV head with IV contrast	May Be Appropriate	O
CT temporal bone without IV contrast	May Be Appropriate (Disagreement)	☢☢☢
CTV head with IV contrast	May Be Appropriate	☢☢☢
US duplex Doppler carotid artery	Usually Not Appropriate	O
US duplex Doppler transcranial	Usually Not Appropriate	O
US head	Usually Not Appropriate	O
Arteriography cervicocerebral	Usually Not Appropriate	☢☢☢
MRI head and internal auditory canal with IV contrast	Usually Not Appropriate	O
MRV head without and with IV contrast	Usually Not Appropriate	O
MRV head without IV contrast	Usually Not Appropriate	O
CT head with IV contrast	Usually Not Appropriate	☢☢☢
CT head without and with IV contrast	Usually Not Appropriate	☢☢☢
CT head without IV contrast	Usually Not Appropriate	☢☢☢
CT temporal bone with IV contrast	Usually Not Appropriate	☢☢☢
CT temporal bone without and with IV contrast	Usually Not Appropriate	☢☢☢

Variant: 2 Pulsatile tinnitus, unilateral or bilateral; suspected retrotympanic lesion on otoscopy. Initial imaging.

Procedure	Appropriateness Category	Relative Radiation Level
CT temporal bone without IV contrast	Usually Appropriate	☢☢☢
CTA head and neck with IV contrast	May Be Appropriate	☢☢☢
CTA head with IV contrast	May Be Appropriate	☢☢☢
CTV head with IV contrast	May Be Appropriate	☢☢☢
US duplex Doppler carotid artery	Usually Not Appropriate	O
US duplex Doppler transcranial	Usually Not Appropriate	O
US head	Usually Not Appropriate	O
Arteriography cervicocerebral	Usually Not Appropriate	☢☢☢
MRA head with IV contrast	Usually Not Appropriate	O
MRA head without and with IV contrast	Usually Not Appropriate	O
MRA head without IV contrast	Usually Not Appropriate	O
MRI head and internal auditory canal with IV contrast	Usually Not Appropriate	O
MRI head and internal auditory canal without and with IV contrast	Usually Not Appropriate	O
MRI head and internal auditory canal without IV contrast	Usually Not Appropriate	O
MRV head with IV contrast	Usually Not Appropriate	O
MRV head without and with IV contrast	Usually Not Appropriate	O
MRV head without IV contrast	Usually Not Appropriate	O
CT head with IV contrast	Usually Not Appropriate	☢☢☢
CT head without and with IV contrast	Usually Not Appropriate	☢☢☢
CT head without IV contrast	Usually Not Appropriate	☢☢☢
CT temporal bone with IV contrast	Usually Not Appropriate	☢☢☢
CT temporal bone without and with IV contrast	Usually Not Appropriate	☢☢☢

Variant: 3 Nonpulsatile tinnitus, unilateral; no hearing loss, and no neurologic deficit, and no trauma. Initial imaging.

Procedure	Appropriateness Category	Relative Radiation Level
MRI head and internal auditory canal without and with IV contrast	Usually Appropriate	O
MRI head and internal auditory canal without IV contrast	May Be Appropriate	O
US duplex Doppler carotid artery	Usually Not Appropriate	O
US duplex Doppler transcranial	Usually Not Appropriate	O
US head	Usually Not Appropriate	O
Arteriography cervicocerebral	Usually Not Appropriate	☢☢☢
MRA head with IV contrast	Usually Not Appropriate	O
MRA head without and with IV contrast	Usually Not Appropriate	O
MRA head without IV contrast	Usually Not Appropriate	O
MRI head and internal auditory canal with IV contrast	Usually Not Appropriate	O
MRV head with IV contrast	Usually Not Appropriate	O
MRV head without and with IV contrast	Usually Not Appropriate	O
MRV head without IV contrast	Usually Not Appropriate	O
CT head with IV contrast	Usually Not Appropriate	☢☢☢
CT head without and with IV contrast	Usually Not Appropriate	☢☢☢
CT head without IV contrast	Usually Not Appropriate	☢☢☢
CT temporal bone with IV contrast	Usually Not Appropriate	☢☢☢
CT temporal bone without and with IV contrast	Usually Not Appropriate	☢☢☢
CT temporal bone without IV contrast	Usually Not Appropriate	☢☢☢
CTA head and neck with IV contrast	Usually Not Appropriate	☢☢☢
CTA head with IV contrast	Usually Not Appropriate	☢☢☢
CTV head with IV contrast	Usually Not Appropriate	☢☢☢

Variant: 4 Nonpulsatile tinnitus, bilateral; no hearing loss, and no neurologic deficit, and no trauma. Initial imaging.

Procedure	Appropriateness Category	Relative Radiation Level
US duplex Doppler carotid artery	Usually Not Appropriate	O
US duplex Doppler transcranial	Usually Not Appropriate	O
US head	Usually Not Appropriate	O
Arteriography cervicocerebral	Usually Not Appropriate	☢☢☢
MRA head with IV contrast	Usually Not Appropriate	O
MRA head without and with IV contrast	Usually Not Appropriate	O
MRA head without IV contrast	Usually Not Appropriate	O
MRI head and internal auditory canal with IV contrast	Usually Not Appropriate	O
MRI head and internal auditory canal without and with IV contrast	Usually Not Appropriate	O
MRI head and internal auditory canal without IV contrast	Usually Not Appropriate	O
MRV head with IV contrast	Usually Not Appropriate	O
MRV head without and with IV contrast	Usually Not Appropriate	O
MRV head without IV contrast	Usually Not Appropriate	O
CT head with IV contrast	Usually Not Appropriate	☢☢☢
CT head without and with IV contrast	Usually Not Appropriate	☢☢☢
CT head without IV contrast	Usually Not Appropriate	☢☢☢
CT temporal bone with IV contrast	Usually Not Appropriate	☢☢☢
CT temporal bone without and with IV contrast	Usually Not Appropriate	☢☢☢
CT temporal bone without IV contrast	Usually Not Appropriate	☢☢☢
CTA head and neck with IV contrast	Usually Not Appropriate	☢☢☢
CTA head with IV contrast	Usually Not Appropriate	☢☢☢
CTV head with IV contrast	Usually Not Appropriate	☢☢☢

Panel Members

Vikas Jain, MD^a; Bruno Policeni, MD, MBA^b; Amy F. Juliano, MD^c; Oliver Adunka, MD^d; Mohit Agarwal, MD^e; Prachi Dubey, MBBS, MPH^f; Elliott R. Friedman, MD^g; Maria K. Gule-Monroe, MD^h; Mari Hagiwara, MDⁱ; Christopher H. Hunt, MD^j; Bruce M. Lo, MD, RDMS, MBA^k; Esther S. Oh, MD, PhD^l; Tanya J. Rath, MD^m; J. Kirk Roberts, MDⁿ; David Schultz, MD^o; M. Reza Taheri, MD, PhD^p; David Zander, MD^q; Judah Burns, MD^r.

Summary of Literature Review

Introduction/Background

Special Imaging Considerations

Initial Imaging Definition

Initial imaging is defined as imaging at the beginning of the care episode for the medical condition defined by the variant. More than one procedure can be considered usually appropriate in the initial imaging evaluation when:

There are procedures that are equivalent alternatives (i.e., only one procedure will be ordered to provide the clinical information to effectively manage the patient’s care)

There are complementary procedures (i.e., more than one procedure is ordered as a set or simultaneously wherein each procedure provides unique clinical information to effectively manage the patient’s care).

Discussion of Procedures by Variant

Variant 1: Pulsatile tinnitus, unilateral or bilateral; No retrotympanic lesion on otoscopy. Initial imaging.

Variant 1: Pulsatile tinnitus, unilateral or bilateral; No retrotympanic lesion on otoscopy. Initial imaging.
A. Arteriography cervicocerebral

Variant 1: Pulsatile tinnitus, unilateral or bilateral; No retrotympanic lesion on otoscopy. Initial imaging.
B. CT head with IV contrast

Variant 1: Pulsatile tinnitus, unilateral or bilateral; No retrotympanic lesion on otoscopy. Initial imaging.
C. CT head without and with IV contrast

Variant 1: Pulsatile tinnitus, unilateral or bilateral; No retrotympanic lesion on otoscopy. Initial imaging.
D. CT head without IV contrast

Variant 1: Pulsatile tinnitus, unilateral or bilateral; No retrotympanic lesion on otoscopy. Initial imaging.
E. CT temporal bone with IV contrast

Variant 1: Pulsatile tinnitus, unilateral or bilateral; No retrotympanic lesion on otoscopy. Initial imaging.
F. CT temporal bone without and with IV contrast

Variant 1: Pulsatile tinnitus, unilateral or bilateral; No retrotympanic lesion on otoscopy. Initial imaging.
G. CT temporal bone without IV contrast

Variant 1: Pulsatile tinnitus, unilateral or bilateral; No retrotympanic lesion on otoscopy. Initial imaging.
H. CTA head and neck with IV contrast

Variant 1: Pulsatile tinnitus, unilateral or bilateral; No retrotympanic lesion on otoscopy. Initial imaging.
I. CTA head with IV contrast

Variant 1: Pulsatile tinnitus, unilateral or bilateral; No retrotympanic lesion on otoscopy. Initial imaging.
J. CTV head with IV contrast

Variant 1: Pulsatile tinnitus, unilateral or bilateral; No retrotympanic lesion on otoscopy. Initial imaging.
K. MRA head with IV contrast

Variant 1: Pulsatile tinnitus, unilateral or bilateral; No retrotympanic lesion on otoscopy. Initial imaging.
L. MRA head without and with IV contrast

Variant 1: Pulsatile tinnitus, unilateral or bilateral; No retrotympanic lesion on otoscopy. Initial imaging.
M. MRA head without IV contrast

Variant 1: Pulsatile tinnitus, unilateral or bilateral; No retrotympanic lesion on otoscopy. Initial imaging.
N. MRI head and internal auditory canal with IV contrast

Variant 1: Pulsatile tinnitus, unilateral or bilateral; No retrotympanic lesion on otoscopy. Initial imaging.
O. MRI head and internal auditory canal without and with IV contrast

Variant 1: Pulsatile tinnitus, unilateral or bilateral; No retrotympanic lesion on otoscopy. Initial imaging.
P. MRI head and internal auditory canal without IV contrast

Variant 1: Pulsatile tinnitus, unilateral or bilateral; No retrotympanic lesion on otoscopy. Initial imaging.
Q. MRV head with IV contrast

Variant 1: Pulsatile tinnitus, unilateral or bilateral; No retrotympanic lesion on otoscopy. Initial imaging.
R. MRV head without and with IV contrast

Variant 1: Pulsatile tinnitus, unilateral or bilateral; No retrotympanic lesion on otoscopy. Initial imaging.
S. MRV head without IV contrast

Variant 1: Pulsatile tinnitus, unilateral or bilateral; No retrotympanic lesion on otoscopy. Initial imaging.
T. US duplex Doppler carotid artery

Variant 1: Pulsatile tinnitus, unilateral or bilateral; No retrotympanic lesion on otoscopy. Initial imaging.
U. US duplex Doppler transcranial

Variant 1: Pulsatile tinnitus, unilateral or bilateral; No retrotympanic lesion on otoscopy. Initial imaging.
V. US head

Variant 2: Pulsatile tinnitus, unilateral or bilateral; suspected retrotympanic lesion on otoscopy. Initial imaging.

Variant 2: Pulsatile tinnitus, unilateral or bilateral; suspected retrotympanic lesion on otoscopy. Initial imaging.
A. Arteriography cervicocerebral

Variant 2: Pulsatile tinnitus, unilateral or bilateral; suspected retrotympanic lesion on otoscopy. Initial imaging.
B. CT head with IV contrast

Variant 2: Pulsatile tinnitus, unilateral or bilateral; suspected retrotympanic lesion on otoscopy. Initial imaging.
C. CT head without and with IV contrast

Variant 2: Pulsatile tinnitus, unilateral or bilateral; suspected retrotympanic lesion on otoscopy. Initial imaging.
D. CT head without IV contrast

Variant 2: Pulsatile tinnitus, unilateral or bilateral; suspected retrotympanic lesion on otoscopy. Initial imaging.
E. CT temporal bone with IV contrast

Variant 2: Pulsatile tinnitus, unilateral or bilateral; suspected retrotympanic lesion on otoscopy. Initial imaging.
F. CT temporal bone without and with IV contrast

Variant 2: Pulsatile tinnitus, unilateral or bilateral; suspected retrotympanic lesion on otoscopy. Initial imaging.
G. CT temporal bone without IV contrast

Variant 2: Pulsatile tinnitus, unilateral or bilateral; suspected retrotympanic lesion on otoscopy. Initial imaging.
H. CTA head and neck with IV contrast

Variant 2: Pulsatile tinnitus, unilateral or bilateral; suspected retrotympanic lesion on otoscopy. Initial imaging.
I. CTA head with IV contrast

Variant 2: Pulsatile tinnitus, unilateral or bilateral; suspected retrotympanic lesion on otoscopy. Initial imaging.
J. CTV head with IV contrast

Variant 2: Pulsatile tinnitus, unilateral or bilateral; suspected retrotympanic lesion on otoscopy. Initial imaging.
K. MRA head with IV contrast

Variant 2: Pulsatile tinnitus, unilateral or bilateral; suspected retrotympanic lesion on otoscopy. Initial imaging.
L. MRA head without and with IV contrast

Variant 2: Pulsatile tinnitus, unilateral or bilateral; suspected retrotympanic lesion on otoscopy. Initial imaging.
M. MRA head without IV contrast

Variant 2: Pulsatile tinnitus, unilateral or bilateral; suspected retrotympanic lesion on otoscopy. Initial imaging.
N. MRI head and internal auditory canal with IV contrast

Variant 2: Pulsatile tinnitus, unilateral or bilateral; suspected retrotympanic lesion on otoscopy. Initial imaging.
O. MRI head and internal auditory canal without and with IV contrast

Variant 2: Pulsatile tinnitus, unilateral or bilateral; suspected retrotympanic lesion on otoscopy. Initial imaging.
P. MRI head and internal auditory canal without IV contrast

Variant 2: Pulsatile tinnitus, unilateral or bilateral; suspected retrotympanic lesion on otoscopy. Initial imaging.
Q. MRV head with IV contrast

Variant 2: Pulsatile tinnitus, unilateral or bilateral; suspected retrotympanic lesion on otoscopy. Initial imaging.
R. MRV head without and with IV contrast

Variant 2: Pulsatile tinnitus, unilateral or bilateral; suspected retrotympanic lesion on otoscopy. Initial imaging.
S. MRV head without IV contrast

Variant 2: Pulsatile tinnitus, unilateral or bilateral; suspected retrotympanic lesion on otoscopy. Initial imaging.
T. US duplex Doppler carotid artery

Variant 2: Pulsatile tinnitus, unilateral or bilateral; suspected retrotympanic lesion on otoscopy. Initial imaging.
U. US duplex Doppler transcranial

Variant 2: Pulsatile tinnitus, unilateral or bilateral; suspected retrotympanic lesion on otoscopy. Initial imaging.
V. US head

Variant 3: Nonpulsatile tinnitus, unilateral; no hearing loss, and no neurologic deficit, and no trauma. Initial imaging.

Variant 3: Nonpulsatile tinnitus, unilateral; no hearing loss, and no neurologic deficit, and no trauma. Initial imaging.
A. Arteriography cervicocerebral

Variant 3: Nonpulsatile tinnitus, unilateral; no hearing loss, and no neurologic deficit, and no trauma. Initial imaging.
B. CT head with IV contrast

Variant 3: Nonpulsatile tinnitus, unilateral; no hearing loss, and no neurologic deficit, and no trauma. Initial imaging.
C. CT head without and with IV contrast

Variant 3: Nonpulsatile tinnitus, unilateral; no hearing loss, and no neurologic deficit, and no trauma. Initial imaging.
D. CT head without IV contrast

Variant 3: Nonpulsatile tinnitus, unilateral; no hearing loss, and no neurologic deficit, and no trauma. Initial imaging.
E. CT temporal bone with IV contrast

Variant 3: Nonpulsatile tinnitus, unilateral; no hearing loss, and no neurologic deficit, and no trauma. Initial imaging.
F. CT temporal bone without and with IV contrast

Variant 3: Nonpulsatile tinnitus, unilateral; no hearing loss, and no neurologic deficit, and no trauma. Initial imaging.
G. CT temporal bone without IV contrast

Variant 3: Nonpulsatile tinnitus, unilateral; no hearing loss, and no neurologic deficit, and no trauma. Initial imaging.
H. CTA head and neck with IV contrast

Variant 3: Nonpulsatile tinnitus, unilateral; no hearing loss, and no neurologic deficit, and no trauma. Initial imaging.
I. CTA head with IV contrast

Variant 3: Nonpulsatile tinnitus, unilateral; no hearing loss, and no neurologic deficit, and no trauma. Initial imaging.
J. CTV head with IV contrast

Variant 3: Nonpulsatile tinnitus, unilateral; no hearing loss, and no neurologic deficit, and no trauma. Initial imaging.
K. MRA head with IV contrast

Variant 3: Nonpulsatile tinnitus, unilateral; no hearing loss, and no neurologic deficit, and no trauma. Initial imaging.
L. MRA head without and with IV contrast

Variant 3: Nonpulsatile tinnitus, unilateral; no hearing loss, and no neurologic deficit, and no trauma. Initial imaging.
M. MRA head without IV contrast

Variant 3: Nonpulsatile tinnitus, unilateral; no hearing loss, and no neurologic deficit, and no trauma. Initial imaging.
N. MRI head and internal auditory canal with IV contrast

Variant 3: Nonpulsatile tinnitus, unilateral; no hearing loss, and no neurologic deficit, and no trauma. Initial imaging.
O. MRI head and internal auditory canal without and with IV contrast

Variant 3: Nonpulsatile tinnitus, unilateral; no hearing loss, and no neurologic deficit, and no trauma. Initial imaging.
P. MRI head and internal auditory canal without IV contrast

Variant 3: Nonpulsatile tinnitus, unilateral; no hearing loss, and no neurologic deficit, and no trauma. Initial imaging.
Q. MRV head with IV contrast

Variant 3: Nonpulsatile tinnitus, unilateral; no hearing loss, and no neurologic deficit, and no trauma. Initial imaging.
R. MRV head without and with IV contrast

Variant 3: Nonpulsatile tinnitus, unilateral; no hearing loss, and no neurologic deficit, and no trauma. Initial imaging.
S. MRV head without IV contrast

Variant 3: Nonpulsatile tinnitus, unilateral; no hearing loss, and no neurologic deficit, and no trauma. Initial imaging.
T. US duplex Doppler carotid artery

Variant 3: Nonpulsatile tinnitus, unilateral; no hearing loss, and no neurologic deficit, and no trauma. Initial imaging.
U. US duplex Doppler transcranial

Variant 3: Nonpulsatile tinnitus, unilateral; no hearing loss, and no neurologic deficit, and no trauma. Initial imaging.
V. US head

Variant 4: Nonpulsatile tinnitus, bilateral; no hearing loss, and no neurologic deficit, and no trauma. Initial imaging.

Variant 4: Nonpulsatile tinnitus, bilateral; no hearing loss, and no neurologic deficit, and no trauma. Initial imaging.
A. Arteriography cervicocerebral

Variant 4: Nonpulsatile tinnitus, bilateral; no hearing loss, and no neurologic deficit, and no trauma. Initial imaging.
B. CT head with IV contrast

Variant 4: Nonpulsatile tinnitus, bilateral; no hearing loss, and no neurologic deficit, and no trauma. Initial imaging.
C. CT head without and with IV contrast

Variant 4: Nonpulsatile tinnitus, bilateral; no hearing loss, and no neurologic deficit, and no trauma. Initial imaging.
D. CT head without IV contrast

Variant 4: Nonpulsatile tinnitus, bilateral; no hearing loss, and no neurologic deficit, and no trauma. Initial imaging.
E. CT temporal bone with IV contrast

Variant 4: Nonpulsatile tinnitus, bilateral; no hearing loss, and no neurologic deficit, and no trauma. Initial imaging.
F. CT temporal bone without and with IV contrast

Variant 4: Nonpulsatile tinnitus, bilateral; no hearing loss, and no neurologic deficit, and no trauma. Initial imaging.
G. CT temporal bone without IV contrast

Variant 4: Nonpulsatile tinnitus, bilateral; no hearing loss, and no neurologic deficit, and no trauma. Initial imaging.
H. CTA head and neck with IV contrast

Variant 4: Nonpulsatile tinnitus, bilateral; no hearing loss, and no neurologic deficit, and no trauma. Initial imaging.
I. CTA head with IV contrast

Variant 4: Nonpulsatile tinnitus, bilateral; no hearing loss, and no neurologic deficit, and no trauma. Initial imaging.
J. CTV head with IV contrast

Variant 4: Nonpulsatile tinnitus, bilateral; no hearing loss, and no neurologic deficit, and no trauma. Initial imaging.
K. MRA head with IV contrast

Variant 4: Nonpulsatile tinnitus, bilateral; no hearing loss, and no neurologic deficit, and no trauma. Initial imaging.
L. MRA head without and with IV contrast

Variant 4: Nonpulsatile tinnitus, bilateral; no hearing loss, and no neurologic deficit, and no trauma. Initial imaging.
M. MRA head without IV contrast

Variant 4: Nonpulsatile tinnitus, bilateral; no hearing loss, and no neurologic deficit, and no trauma. Initial imaging.
N. MRI head and internal auditory canal with IV contrast

Variant 4: Nonpulsatile tinnitus, bilateral; no hearing loss, and no neurologic deficit, and no trauma. Initial imaging.
O. MRI head and internal auditory canal without and with IV contrast

Variant 4: Nonpulsatile tinnitus, bilateral; no hearing loss, and no neurologic deficit, and no trauma. Initial imaging.
P. MRI head and internal auditory canal without IV contrast

Variant 4: Nonpulsatile tinnitus, bilateral; no hearing loss, and no neurologic deficit, and no trauma. Initial imaging.
Q. MRV head with IV contrast

Variant 4: Nonpulsatile tinnitus, bilateral; no hearing loss, and no neurologic deficit, and no trauma. Initial imaging.
R. MRV head without and with IV contrast

Variant 4: Nonpulsatile tinnitus, bilateral; no hearing loss, and no neurologic deficit, and no trauma. Initial imaging.
S. MRV head without IV contrast

Variant 4: Nonpulsatile tinnitus, bilateral; no hearing loss, and no neurologic deficit, and no trauma. Initial imaging.
T. US duplex Doppler carotid artery

Variant 4: Nonpulsatile tinnitus, bilateral; no hearing loss, and no neurologic deficit, and no trauma. Initial imaging.
U. US duplex Doppler transcranial

Variant 4: Nonpulsatile tinnitus, bilateral; no hearing loss, and no neurologic deficit, and no trauma. Initial imaging.
V. US head

Summary of Highlights

Supporting Documents

The evidence table, literature search, and appendix for this topic are available at https://acsearch.acr.org/list. The appendix includes the strength of evidence assessment and the final rating round tabulations for each recommendation.

For additional information on the Appropriateness Criteria methodology and other supporting documents, please go to the ACR website at https://www.acr.org/Clinical-Resources/Clinical-Tools-and-Reference/Appropriateness-Criteria.

Appropriateness Category Names and Definitions

Appropriateness Category Name	Appropriateness Rating	Appropriateness Category Definition
Usually Appropriate	7, 8, or 9	The imaging procedure or treatment is indicated in the specified clinical scenarios at a favorable risk-benefit ratio for patients.
May Be Appropriate	4, 5, or 6	The imaging procedure or treatment may be indicated in the specified clinical scenarios as an alternative to imaging procedures or treatments with a more favorable risk-benefit ratio, or the risk-benefit ratio for patients is equivocal.
May Be Appropriate (Disagreement)	5	The individual ratings are too dispersed from the panel median. The different label provides transparency regarding the panel’s recommendation. “May be appropriate” is the rating category and a rating of 5 is assigned.
Usually Not Appropriate	1, 2, or 3	The imaging procedure or treatment is unlikely to be indicated in the specified clinical scenarios, or the risk-benefit ratio for patients is likely to be unfavorable.

Relative Radiation Level Information

Potential adverse health effects associated with radiation exposure are an important factor to consider when selecting the appropriate imaging procedure. Because there is a wide range of radiation exposures associated with different diagnostic procedures, a relative radiation level (RRL) indication has been included for each imaging examination. The RRLs are based on effective dose, which is a radiation dose quantity that is used to estimate population total radiation risk associated with an imaging procedure. Patients in the pediatric age group are at inherently higher risk from exposure, because of both organ sensitivity and longer life expectancy (relevant to the long latency that appears to accompany radiation exposure). For these reasons, the RRL dose estimate ranges for pediatric examinations are lower as compared with those specified for adults (see Table below). Additional information regarding radiation dose assessment for imaging examinations can be found in the ACR Appropriateness Criteria^® Radiation Dose Assessment Introduction document.

Relative Radiation Level Designations
Relative Radiation Level*	Adult Effective Dose Estimate Range	Pediatric Effective Dose Estimate Range
O	0 mSv	0 mSv
☢	<0.1 mSv	<0.03 mSv
☢☢	0.1-1 mSv	0.03-0.3 mSv
☢☢☢	1-10 mSv	0.3-3 mSv
☢☢☢☢	10-30 mSv	3-10 mSv
☢☢☢☢☢	30-100 mSv	10-30 mSv
*RRL assignments for some of the examinations cannot be made, because the actual patient doses in these procedures vary as a function of a number of factors (e.g., region of the body exposed to ionizing radiation, the imaging guidance that is used). The RRLs for these examinations are designated as “Varies.”

References

1.	Krishnan A, Mattox DE, Fountain AJ, Hudgins PA. CT arteriography and venography in pulsatile tinnitus: preliminary results. AJNR Am J Neuroradiol. 2006;27(8):1635-1638.
2.	National Institutes of Health. National Institute on Deafness and Other Communication Disorders (NIDCD). Quick Statistics. Available at: http://www.nidcd.nih.gov/health/statistics/Pages/quick.aspx.
3.	Coelho CB, Santos R, Campara KF, Tyler R. Classification of Tinnitus: Multiple Causes with the Same Name. [Review]. Otolaryngol Clin North Am. 53(4):515-529, 2020 Aug.
4.	Abdalkader M, Nguyen TN, Norbash AM, et al. State of the Art: Venous Causes of Pulsatile Tinnitus and Diagnostic Considerations Guiding Endovascular Therapy. [Review]. Radiology. 300(1):2-16, 2021 07.
5.	Fife TD. Neuro-otology of Systemic Disease. In: Lewis SL, ed. Neurological Disorders due to Systemic Disease. 1st ed. Oxford, UK: Wiley-Blackwell Health Sciences; 2013:145-54.
6.	Dalrymple SN, Lewis SH, Philman S. Tinnitus: Diagnosis and Management. [Review]. Am Fam Physician. 103(11):663-671, 2021 06 01.
7.	Tunkel DE, Bauer CA, Sun GH, et al. Clinical practice guideline: tinnitus. Otolaryngol Head Neck Surg 2014;151:S1-S40.
8.	Sharma A, Kirsch CFE, Aulino JM, et al. ACR Appropriateness Criteria® Hearing Loss and/or Vertigo. J Am Coll Radiol 2018;15:S321-S31.
9.	Shih RY, Burns J, Ajam AA, et al. ACR Appropriateness Criteria® Head Trauma: 2021 Update. J Am Coll Radiol 2021;18:S13-S36.
10.	Ledbetter LN, Burns J, Shih RY, et al. ACR Appropriateness Criteria R Cerebrovascular Diseases-Aneurysm, Vascular Malformation, and Subarachnoid Hemorrhage. Journal of the American College of Radiology. 18(11S):S283-S304, 2021 11.J. Am. Coll. Radiol.. 18(11S):S283-S304, 2021 11.
11.	Kumar R, Rice S, Lingam RK. Detecting causes of pulsatile tinnitus on CT arteriography-venography: A pictorial review. [Review]. Eur J Radiol. 139:109722, 2021 Jun.
12.	Mattox DE, Hudgins P. Algorithm for evaluation of pulsatile tinnitus. Acta Otolaryngol. 2008;128(4):427-431.
13.	Hofmeier B, Wolpert S, Aldamer ES, et al. Reduced sound-evoked and resting-state BOLD fMRI connectivity in tinnitus. Neuroimage (Amst). 20:637-649, 2018.
14.	Yakunina N, Kim SS, Nam EC. BOLD fMRI effects of transcutaneous vagus nerve stimulation in patients with chronic tinnitus. PLoS ONE. 13(11):e0207281, 2018.
15.	Amukotuwa SA, Marks MP, Zaharchuk G, Calamante F, Bammer R, Fischbein N. Arterial Spin-Labeling Improves Detection of Intracranial Dural Arteriovenous Fistulas with MRI. AJNR Am J Neuroradiol. 39(4):669-677, 2018 Apr.
16.	Farb RI, Agid R, Willinsky RA, Johnstone DM, Terbrugge KG. Cranial dural arteriovenous fistula: diagnosis and classification with time-resolved MR angiography at 3T. AJNR Am J Neuroradiol. 30(8):1546-51, 2009 Sep.
17.	Grossberg JA, Howard BM, Saindane AM. The use of contrast-enhanced, time-resolved magnetic resonance angiography in cerebrovascular pathology. [Review]. Neurosurgical Focus. 47(6):E3, 2019 12 01.
18.	Nishimura S, Hirai T, Sasao A, et al. Evaluation of dural arteriovenous fistulas with 4D contrast-enhanced MR angiography at 3T. AJNR Am J Neuroradiol. 31(1):80-5, 2010 Jan.
19.	Schoeff S, Nicholas B, Mukherjee S, Kesser BW. Imaging prevalence of sigmoid sinus dehiscence among patients with and without pulsatile tinnitus. Otolaryngol Head Neck Surg. 150(5):841-6, 2014 May.
20.	Waldvogel D, Mattle HP, Sturzenegger M, Schroth G. Pulsatile tinnitus--a review of 84 patients. J Neurol. 245(3):137-42, 1998 Mar.
21.	Dong C, Zhao PF, Yang JG, Liu ZH, Wang ZC. Incidence of vascular anomalies and variants associated with unilateral venous pulsatile tinnitus in 242 patients based on dual-phase contrast-enhanced computed tomography. Chin Med J. 128(5):581-5, 2015 Mar 05.
22.	Nicholson P, Brinjikji W, Radovanovic I, et al. Venous sinus stenting for idiopathic intracranial hypertension: a systematic review and meta-analysis. J Neurointerv Surg. 11(4):380-385, 2019 Apr.
23.	Sonmez G, Basekim CC, Ozturk E, Gungor A, Kizilkaya E. Imaging of pulsatile tinnitus: a review of 74 patients. Clin Imaging. 2007;31(2):102-108.
24.	Zhao P, Wang Z, Xian J, Yan F, Liu Z. Persistent petrosquamosal sinus in adults: qualitative imaging evaluation on high-resolution CT venography. Acta Radiol. 2014;55(2):225-230.
25.	Grewal AK, Kim HY, Comstock RH 3rd, Berkowitz F, Kim HJ, Jay AK. Clinical presentation and imaging findings in patients with pulsatile tinnitus and sigmoid sinus diverticulum/dehiscence. Otol Neurotol. 35(1):16-21, 2014 Jan.
26.	Harvey RS, Hertzano R, Kelman SE, Eisenman DJ. Pulse-synchronous tinnitus and sigmoid sinus wall anomalies: descriptive epidemiology and the idiopathic intracranial hypertension patient population. Otol Neurotol 2014;35:7-15.
27.	Liu Z, Chen C, Wang Z, et al. Sigmoid sinus diverticulum and pulsatile tinnitus: analysis of CT scans from 15 cases. Acta Radiol. 54(7):812-6, 2013 Sep.
28.	Madani G, Connor SE. Imaging in pulsatile tinnitus. [Review] [33 refs]. Clin Radiol. 64(3):319-28, 2009 Mar.
29.	Narvid J, Do HM, Blevins NH, Fischbein NJ. CT angiography as a screening tool for dural arteriovenous fistula in patients with pulsatile tinnitus: feasibility and test characteristics. AJNR Am J Neuroradiol. 2011;32(3):446-453.
30.	Ellenstein A, Yusuf N, Hallett M. Middle ear myoclonus: two informative cases and a systematic discussion of myogenic tinnitus. Tremor Other Hyperkinet Mov (N Y) 2013;3.
31.	Fox GN, Baer MT. Palatal myoclonus and tinnitus in children. West J Med 1991;154:98-102.
32.	Park SN, Bae SC, Lee GH, et al. Clinical characteristics and therapeutic response of objective tinnitus due to middle ear myoclonus: a large case series. Laryngoscope 2013;123:2516-20.
33.	Sinclair CF, Gurey LE, Blitzer A. Palatal myoclonus: algorithm for management with botulinum toxin based on clinical disease characteristics. Laryngoscope 2014;124:1164-9.
34.	Wu V, Cooke B, Eitutis S, Simpson MTW, Beyea JA. Approach to tinnitus management. [Review]. Can Fam Physician. 64(7):491-495, 2018 07.
35.	In 't Veld M, Fronczek R, de Laat JA, Kunst HPM, Meijer FJA, Willems PWA. The Incidence of Cranial Arteriovenous Shunts in Patients With Pulsatile Tinnitus: A Prospective Observational Study. Otol Neurotol. 39(5):648-653, 2018 06.
36.	Remley KB, Coit WE, Harnsberger HR, Smoker WR, Jacobs JM, McIff EB. Pulsatile tinnitus and the vascular tympanic membrane: CT, MR, and angiographic findings. Radiology 1990;174:383-9.
37.	Pelkonen O, Tikkakoski T, Luotonen J, Sotaniemi K. Pulsatile tinnitus as a symptom of cervicocephalic arterial dissection. J Laryngol Otol. 2004;118(3):193-198.
38.	von Babo M, De Marchis GM, Sarikaya H, et al. Differences and similarities between spontaneous dissections of the internal carotid artery and the vertebral artery. Stroke. 2013;44(6):1537-1542.
39.	Sismanis A. Pulsatile tinnitus. Otolaryngol Clin North Am. 2003;36(2):389-402, viii.
40.	Hillman TA, Kertesz TR, Hadley K, Shelton C. Reversible peripheral vestibulopathy: the treatment of superior canal dehiscence. Otolaryngol Head Neck Surg. 2006;134(3):431-436.
41.	Jacky Chen CH, Nguyen T, Udawatta M, et al. Clinical Assessment of Patients with Bilateral Superior Semicircular Canal Dehiscence. World Neurosurg. 126:e1549-e1552, 2019 Jun.
42.	Kline NL, Angster K, Archer E, et al. Association of pulse synchronous tinnitus and sigmoid sinus wall abnormalities in patients with idiopathic intracranial hypertension. Am J Otolaryngol. 41(6):102675, 2020 Nov - Dec.
43.	Li X, Qiu X, Ding H, et al. Effects of different morphologic abnormalities on hemodynamics in patients with venous pulsatile tinnitus: A four-dimensional flow magnetic resonance imaging study. J Magn Reson Imaging. 53(6):1744-1751, 2021 06.
44.	Lao Z, Sha Y, Chen B, Dai CF, Huang WH, Cheng YS. Labyrinthine sequestrum: four case studies. Otolaryngol Head Neck Surg. 147(3):535-7, 2012 Sep.
45.	Cho IK, Jung JY, Yoo DS, Suh MW. 3-Dimensional reconstruction of the venous system in patients suffering from pulsatile tinnitus. Acta Otolaryngol. 2012;132(3):285-289.
46.	Cunnane MB. Imaging of Tinnitus. [Review]. Neuroimaging Clin N Am. 29(1):49-56, 2019 Feb.
47.	Mundada P, Singh A, Lingam RK. CT arteriography and venography in the evaluation of Pulsatile tinnitus with normal otoscopic examination. Laryngoscope. 125(4):979-84, 2015 Apr.
48.	Christie A, Teasdale E. A comparative review of multidetector CT angiography and MRI in the diagnosis of jugular foramen lesions. Clin Radiol. 65(3):213-7, 2010 Mar.
49.	Bathla G, Hegde A, Nagpal P, Agarwal A. Imaging in Pulsatile Tinnitus: Case Based Review. J Clin Imaging Sci. 10:84, 2020.
50.	Hewes D, Morales R, Raghavan P, Eisenman DJ. Pattern and severity of transverse sinus stenosis in patients with pulsatile tinnitus associated with sigmoid sinus wall anomalies. Laryngoscope. 130(4):1028-1033, 2020 04.
51.	Eisenman DJ, Raghavan P, Hertzano R, Morales R. Evaluation and treatment of pulsatile tinnitus associated with sigmoid sinus wall anomalies. Laryngoscope. 128 Suppl 2:S1-S13, 2018 10.
52.	Ettyreddy AR, Shew MA, Durakovic N, et al. Prevalence, Surgical Management, and Audiologic Impact of Sigmoid Sinus Dehiscence Causing Pulsatile Tinnitus. Otol Neurotol. 42(1):82-91, 2021 01.
53.	Liu Z, He X, Du R, Wang G, Gong S, Wang Z. Hemodynamic Changes in the Sigmoid Sinus of Patients With Pulsatile Tinnitus Induced by Sigmoid Sinus Wall Anomalies. Otol Neurotol. 41(2):e163-e167, 2020 02.
54.	Wang AC, Nelson AN, Pino C, Svider PF, Hong RS, Chan E. Management of Sigmoid Sinus Associated Pulsatile Tinnitus: A Systematic Review of the Literature. [Review]. Otol Neurotol. 38(10):1390-1396, 2017 12.
55.	Wang D, Zhao Y, Tong B. Treatment of pulsatile tinnitus caused by anomalies of the sigmoid sinus wall via combined internal and external sigmoid sinus wall reconstruction with 3D temporal bone CT guidance. Eur Arch Otorhinolaryngol. 277(9):2439-2445, 2020 Sep.
56.	Zhao P, Ding H, Lv H, et al. CT venography correlate of transverse sinus stenosis and venous transstenotic pressure gradient in unilateral pulsatile tinnitus patients with sigmoid sinus wall anomalies. Eur Radiol. 31(5):2896-2902, 2021 May.
57.	Lenck S, Labeyrie MA, Vallee F, et al. Stent Placement for Disabling Pulsatile Tinnitus Caused by a Lateral Sinus Stenosis: A Retrospective Study. Oper Neurosurg (Hagerstown). 13(5):560-565, 2017 10 01.
58.	Deuschl C, Goricke S, Gramsch C, et al. Value of DSA in the diagnostic workup of pulsatile tinnitus. PLoS One 2015;10:e0117814.
59.	Noguchi K, Melhem ER, Kanazawa T, Kubo M, Kuwayama N, Seto H. Intracranial dural arteriovenous fistulas: evaluation with combined 3D time-of-flight MR angiography and MR digital subtraction angiography. AJR Am J Roentgenol 2004;182:183-90.
60.	Chadha NK, Weiner GM. Vascular loops causing otological symptoms: a systematic review and meta-analysis. Clin Otolaryngol 2008;33:5-11.
61.	Guevara N, Deveze A, Buza V, Laffont B, Magnan J. Microvascular decompression of cochlear nerve for tinnitus incapacity: pre-surgical data, surgical analyses and long-term follow-up of 15 patients. Eur Arch Otorhinolaryngol. 2008;265(4):397-401.
62.	Nowe V, De Ridder D, Van de Heyning PH, et al. Does the location of a vascular loop in the cerebellopontine angle explain pulsatile and non-pulsatile tinnitus? Eur Radiol. 2004;14(12):2282-2289.
63.	Levine SB, Snow JB Jr. Pulsatile tinnitus. [Review] [38 refs]. Laryngoscope. 97(4):401-6, 1987 Apr.
64.	Weissman JL, Hirsch BE. Imaging of tinnitus: a review. [Review] [49 refs]. Radiology. 216(2):342-9, 2000 Aug.
65.	Li Y, Chen H, He L, et al. Hemodynamic assessments of venous pulsatile tinnitus using 4D-flow MRI. Neurology. 91(6):e586-e593, 2018 08 07.
66.	Farid M, Alawamry A, Zaitoun MMA, Bessar AA, Darwish EAF. Relentless pulsatile tinnitus secondary to dural sinovenous stenosis: is endovascular sinus stenting the answer?. Clin Radiol. 76(7):526-531, 2021 07.
67.	Sundararajan SH, Ramos AD, Kishore V, et al. Dural Venous Sinus Stenosis: Why Distinguishing Intrinsic-versus-Extrinsic Stenosis Matters. AJNR Am J Neuroradiol. 42(2):288-296, 2021 01.
68.	Gedikli O, Kemal O, Yildirim U, et al. Is there an association between the parameters of arterial stiffness and tinnitus?. Acta Otolaryngol (Stockh). 140(2):128-132, 2020 Feb.
69.	Yeh SJ, Tsai LK, Jeng JS. Clinical and carotid ultrasonographic features of intracranial dural arteriovenous fistulas in patients with and without Pulsatile Tinnitus. J Neuroimaging. 2010;20(4):354-358.
70.	Bierry G, Riehm S, Marcellin L, Stierle JL, Veillon F. Middle ear adenomatous tumor: a not so rare glomus tympanicum-mimicking lesion. J Neuroradiol. 37(2):116-21, 2010 May.
71.	Lewis S, Chowdhury E, Stockdale D, Kennedy V, Guideline Committee. Assessment and management of tinnitus: summary of NICE guidance. BMJ. 368:m976, 2020 Mar 31.
72.	Chari DA, Limb CJ. Tinnitus. [Review]. Med Clin North Am. 102(6):1081-1093, 2018 Nov.
73.	Lee CF, Lin MC, Lin HT, Lin CL, Wang TC, Kao CH. Increased risk of tinnitus in patients with temporomandibular disorder: a retrospective population-based cohort study. Eur Arch Otorhinolaryngol 2016;273:203-8.
74.	Funnell JP, Craven CL, Thompson SD, et al. Pulsatile versus non-pulsatile tinnitus in idiopathic intracranial hypertension. Acta Neurochir (Wien). 160(10):2025-2029, 2018 10.
75.	Ocak E, Kocaoz D, Acar B, Topcuoglu M. Radiological Evaluation of Inner Ear with Computed Tomography in Patients with Unilateral Non-Pulsatile Tinnitus. J. int. adv. otol.. 14(2):273-277, 2018 Aug.
76.	Willinsky RA. Tinnitus: imaging algorithms. Can Assoc Radiol J 1992;43:93-9.
77.	Gimsing S. Vestibular schwannoma: when to look for it? J Laryngol Otol. 2010;124(3):258-264.
78.	Cao W, Hou Z, Wang F, Jiang Q, Shen W, Yang S. Larger tumor size and female gender suggest better tinnitus prognosis after surgical treatment in vestibular schwannoma patients with tinnitus. Acta Otolaryngol (Stockh). 140(5):373-377, 2020 May.
79.	Jiang ZY, Kutz JW, Jr., Roland PS, Isaacson B. Intracochlear schwannomas confined to the otic capsule. Otol Neurotol. 2011;32(7):1175-1179.
80.	Springborg JB, Poulsgaard L, Thomsen J. Nonvestibular schwannoma tumors in the cerebellopontine angle: a structured approach and management guidelines. Skull Base 2008;18:217-27.
81.	Choi KJ, Sajisevi MB, Kahmke RR, Kaylie DM. Incidence of Retrocochlear Pathology Found on MRI in Patients With Non-Pulsatile Tinnitus. Otol Neurotol. 36(10):1730-4, 2015 Dec.
82.	Arai M, Takada T, Nozue M. Orthostatic tinnitus: an otological presentation of spontaneous intracranial hypotension. Auris Nasus Larynx 2003;30:85-7.
83.	Isildak H, Albayram S, Isildak H, Spontaneous intracranial hypotension syndrome accompanied by bilateral hearing loss and venous engorgement in the internal acoustic canal and positional change of audiography. Journal of Craniofacial Surgery. 21(1):165-7, 2010 Jan.
84.	Loureiro RM, Sumi DV, Lemos MD, et al. The role of magnetic resonance imaging in Meniere disease: the current state of endolymphatic hydrops evaluation. Einstein. 17(1):eMD4743, 2019 Feb 25.
85.	Paskoniene A, Baltagalviene R, Lengvenis G, et al. The Importance of the Temporal Bone 3T MR Imaging in the Diagnosis of Meniere's Disease. Otol Neurotol. 41(2):235-241, 2020 02.
86.	Patel VA, Oberman BS, Zacharia TT, Isildak H. Magnetic resonance imaging findings in Meniere's disease. J Laryngol Otol. 131(7):602-607, 2017 Jul.
87.	Perez-Carpena P, Lopez-Escamez JA. Current Understanding and Clinical Management of Meniere's Disease: A Systematic Review. Semin Neurol. 40(1):138-150, 2020 Feb.
88.	Pyykko I, Zou J, Poe D, Nakashima T, Naganawa S. Magnetic resonance imaging of the inner ear in Meniere's disease. [Review]. Otolaryngol Clin North Am. 43(5):1059-80, 2010 Oct.
89.	Liudahl AA, Davis AB, Liudahl DS, Maley J, Policeni B, Hansen MR. Diagnosis of small vestibular schwannomas using constructive interference steady state sequence. Laryngoscope. 128(9):2128-2132, 2018 09.
90.	Chole RA, Parker WS. Tinnitus and vertigo in patients with temporomandibular disorder. Arch Otolaryngol Head Neck Surg 1992;118:817-21.
91.	Park RJ, Moon JD. Prevalence and risk factors of tinnitus: the Korean National Health and Nutrition Examination Survey 2010-2011, a cross-sectional study. Clin Otolaryngol 2014;39:89-94.
92.	Chemali Z, Nehme R, Fricchione G. Sensory neurologic disorders: Tinnitus. [Review]. Handb. clin. neurol.. 165:365-381, 2019.
93.	Oosterloo BC, Croll PH, de Jong RJB, Ikram MK, Goedegebure A. Prevalence of Tinnitus in an Aging Population and Its Relation to Age and Hearing Loss. Otolaryngol Head Neck Surg. 164(4):859-868, 2021 04.
94.	Shapiro SB, Noij KS, Naples JG, Samy RN. Hearing Loss and Tinnitus. [Review]. Med Clin North Am. 105(5):799-811, 2021 Sep.
95.	American College of Radiology. ACR Appropriateness Criteria® Radiation Dose Assessment Introduction. Available at: https://edge.sitecorecloud.io/americancoldf5f-acrorgf92a-productioncb02-3650/media/ACR/Files/Clinical/Appropriateness-Criteria/ACR-Appropriateness-Criteria-Radiation-Dose-Assessment-Introduction.pdf.

Disclaimer

The ACR Committee on Appropriateness Criteria and its expert panels have developed criteria for determining appropriate imaging examinations for diagnosis and treatment of specified medical condition(s). These criteria are intended to guide radiologists, radiation oncologists and referring physicians in making decisions regarding radiologic imaging and treatment. Generally, the complexity and severity of a patient’s clinical condition should dictate the selection of appropriate imaging procedures or treatments. Only those examinations generally used for evaluation of the patient’s condition are ranked. Other imaging studies necessary to evaluate other co-existent diseases or other medical consequences of this condition are not considered in this document. The availability of equipment or personnel may influence the selection of appropriate imaging procedures or treatments. Imaging techniques classified as investigational by the FDA have not been considered in developing these criteria; however, study of new equipment and applications should be encouraged. The ultimate decision regarding the appropriateness of any specific radiologic examination or treatment must be made by the referring physician and radiologist in light of all the circumstances presented in an individual examination.